These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27129184)

  • 1. Dysregulation of ossification-related miRNAs in circulating osteogenic progenitor cells obtained from patients with aortic stenosis.
    Takahashi K; Satoh M; Takahashi Y; Osaki T; Nasu T; Tamada M; Okabayashi H; Nakamura M; Morino Y
    Clin Sci (Lond); 2016 Jul; 130(13):1115-24. PubMed ID: 27129184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered microRNAs in bicuspid aortic valve: a comparison between stenotic and insufficient valves.
    Nigam V; Sievers HH; Jensen BC; Sier HA; Simpson PC; Srivastava D; Mohamed SA
    J Heart Valve Dis; 2010 Jul; 19(4):459-65. PubMed ID: 20845893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered MicroRNA Expression Is Responsible for the Pro-Osteogenic Phenotype of Interstitial Cells in Calcified Human Aortic Valves.
    Song R; Fullerton DA; Ao L; Zhao KS; Reece TB; Cleveland JC; Meng X
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-638 inhibits human aortic valve interstitial cell calcification by targeting Sp7.
    Jiao W; Zhang D; Wang D; Xu R; Tang L; Zhao M; Xu R
    J Cell Mol Med; 2019 Aug; 23(8):5292-5302. PubMed ID: 31140727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MALAT1 sponges miR-204 to promote osteoblast differentiation of human aortic valve interstitial cells through up-regulating Smad4.
    Xiao X; Zhou T; Guo S; Guo C; Zhang Q; Dong N; Wang Y
    Int J Cardiol; 2017 Sep; 243():404-412. PubMed ID: 28522163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-449c-5p inhibits osteogenic differentiation of human VICs through Smad4-mediated pathway.
    Xu R; Zhao M; Yang Y; Huang Z; Shi C; Hou X; Zhao Y; Chen B; Xiao Z; Liu J; Miao Q; Dai J
    Sci Rep; 2017 Aug; 7(1):8740. PubMed ID: 28821833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AntagomiR-29b inhibits vascular and valvular calcification and improves heart function in rats.
    Fang M; Liu K; Li X; Wang Y; Li W; Li B
    J Cell Mol Med; 2020 Oct; 24(19):11546-11557. PubMed ID: 32845082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis.
    Rattazzi M; Faggin E; Bertacco E; Buso R; Puato M; Plebani M; Zaninotto M; Condotta D; Zoppellaro G; Pagliani L; Tarantini G; Iliceto S; Covolo E; Faggian G; Onorati F; Dodonov M; Daniotti A; Pantano P; Olivari Z; Benfari G; Pauletto P
    J Cardiovasc Transl Res; 2018 Aug; 11(4):329-338. PubMed ID: 29777507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.
    van der Ven CF; Wu PJ; Tibbitt MW; van Mil A; Sluijter JP; Langer R; Aikawa E
    Clin Sci (Lond); 2017 Feb; 131(3):181-195. PubMed ID: 28057890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
    Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic valve calcification as a predictor of location and severity of paravalvular regurgitation after transcatheter aortic valve implantation.
    Koh EY; Lam KY; Bindraban NR; Cocchieri R; Planken RN; Koch KT; Baan J; de Mol BA; Marquering HA
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):345-50. PubMed ID: 25487234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry.
    Onorati F; D'Errigo P; Barbanti M; Rosato S; Covello RD; Maraschini A; Ranucci M; Santoro G; Tamburino C; Grossi C; Santini F; Menicanti L; Seccareccia F;
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1529-39. PubMed ID: 23856202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent of aortic annulus calcification is a predictor of postprocedural eccentricity and paravalvular regurgitation: a pre- and postinterventional cardiac computed tomography angiography study.
    Bekeredjian R; Bodingbauer D; Hofmann NP; Greiner S; Schuetz M; Geis NA; Kauczor HU; Bryant M; Chorianopoulos E; Pleger ST; Mereles D; Katus HA; Korosoglou G
    J Invasive Cardiol; 2015 Mar; 27(3):172-80. PubMed ID: 25740972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience.
    Czerwińska K; Hryniewiecki T; Oręziak A; Dąbrowski M; Michałowska I; Witkowski A; Demkow M; Stępińska J; Orłowska Baranowska E; Rużyłło W
    Kardiol Pol; 2012; 70(2):121-8. PubMed ID: 22427074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with severe aortic stenosis and reduced ejection fraction: earlier recovery of left ventricular systolic function after transcatheter aortic valve implantation compared with surgical valve replacement.
    Bauer F; Coutant V; Bernard M; Stepowski D; Tron C; Cribier A; Bessou JP; Eltchaninoff H
    Echocardiography; 2013 Sep; 30(8):865-70. PubMed ID: 23489257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic characterization of aortic annulus geometry and morphology with multimodality imaging: predictive value for aortic regurgitation after transcatheter aortic valve replacement.
    Masri A; Schoenhagen P; Svensson L; Kapadia SR; Griffin BP; Tuzcu EM; Desai MY
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1847-54. PubMed ID: 23870156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter aortic valve implantation in a patient with severe aortic insufficiency and minimal aortic annular calcification.
    Nakamura Y; Teefy P; Kiaii B; Syed J; Jones PM; Bainbridge D; Wisenberg G; Chu MW
    Can J Cardiol; 2013 Sep; 29(9):1138.e9-1138.e11. PubMed ID: 23465340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
    Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
    Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.
    Meredith Am IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Allocco DJ; Dawkins KD
    J Am Coll Cardiol; 2014 Sep; 64(13):1339-48. PubMed ID: 25257635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system.
    Leber AW; Kasel M; Ischinger T; Ebersberger UH; Antoni D; Schmidt M; Riess G; Renz V; Huber A; Helmberger T; Hoffmann E
    Int J Cardiol; 2013 Jul; 166(3):652-7. PubMed ID: 22197118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.